 Connection
Mayumi Nakagawa to Retrospective Studies
This is a "connection" page, showing publications Mayumi Nakagawa has written about Retrospective Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.129 |
|
|
|
-
Kim KH, Horn TD, Pharis J, Kincannon J, Jones R, O'Bryan K, Myers J, Nakagawa M. Phase 1 clinical trial of intralesional injection of Candida antigen for the treatment of warts. Arch Dermatol. 2010 Dec; 146(12):1431-3.
Score: 0.037
-
Wyble AJ, Sethapati VR, Post SR, McAloon H, Green N, Nakagawa M, Cottler-Fox M, Drobena G. Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services. J Clin Apher. 2025 Aug; 40(4):e70048.
Score: 0.026
-
Manabe T, Machida H, Mizushima T, Endo S, Takeuchi J, Matsuo K, Yasaka M, Kajiwara H, Fujii S, Nakagawa M, Koike J, Chosokabe M, Miyagi E, Kato K, Suzuki N, Mikami M. Validation of the 2023 FIGO staging system and its concordance with the JSGO guidelines in endometrial cancer: A multi-institutional retrospective study in Japan. J Obstet Gynaecol Res. 2025 Aug; 51(8):e70049.
Score: 0.026
-
Toy P, Hollis-Perry KM, Jun J, Nakagawa M. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Transfusion. 2004 Dec; 44(12):1683-8.
Score: 0.024
-
Kamiya T, Hira D, Hoshino N, Kurihara M, Nakagawa M, Sasaki M, Terada T. Low Body Mass Index and Myeloablative Conditioning Regimen Prolong the Duration of Parenteral Nutrition During Hematopoietic Stem Cell Transplantation. Ann Nutr Metab. 2019; 74(2):107-114.
Score: 0.016
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|